Meifeng (cefalexin sustained-release tablets)_Anti-infectives_Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

中

中文 English

About Us
- Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
- Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
- Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
- Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
- Founded in 1995, Hansoh is a leading R&D-driven pharmaceutical company in China.
News
- Company News
- Media Focus
- With the objective of 'creating excellence in China's pharmaceuticals and add momentum to "Made in China"',Hansoh endeavors to make its own contribution to the “Healthy China 2030” master plan.
- With the objective of 'creating excellence in China's pharmaceuticals and add momentum to "Made in China"',Hansoh endeavors to make its own contribution to the “Healthy China 2030” master plan.
Products
- Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- Hansoh Pharma has been committed to improving human health through continuous innovation, especially in major disease treatment fields including oncology, CNS, anti-infectives and diabetes.Constantly evolving, Hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
R&D
- Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
- Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
- Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
- Hansoh has been holding on to the strategy of technology and innovation, and established R&D centers located in Lianyungang and Shanghai.
Services
- Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- Hansoh pursuits the philosophy of “Professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
Contact Us
- Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- Hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.



Meifeng (cefalexin sustained-release tablets)

cefalexin sustained-release tablets

English Name: Cefalexin Extend-release tablets
Chinese Pinyin: Toubao'anbian Huanshipia

The main ingredient of this product is cefalexin.

Chemical Name: (6R,7R)-3-methyl-7-[(R)-2-amino-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2. 0] oct-2-ene-2-carboxylic acid monohydrate.

/en/upload/images/2017/10/10/b0cab0aa9ab445a39bbb207b82fcb426.png

【Name】	Common Name: Cefalexin Extend-release tablets Brand Name: Mei Feng English Name: Cefalexin Extend-release tablets Chinese Pinyin: Toubao'anbian Huanshipia
【Ingredients】	The main ingredient of this product is cefalexin. Chemical Name: (6R,7R)-3-methyl-7-[(R)-2-amino-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2. 0] oct-2-ene-2-carboxylic acid monohydrate. Molecular Formula: C₁₆H₁₇N₃O₄S.H₂O Molecular Weight: 365.4
【Description】	This product is a film-coated tablet, which is off-white after removing the film
【Indication】	This product is suitable for mild to moderate infections in the following parts caused by sensitive strains such as Staphylococcus aureus, hemolytic streptococcus, pneumococcal, Escherichia coli, Klebsiella pneumoniae, influenza bacillus, and dysentery bacillus; tonsillitis, peritonsillitis, throat inflammation, bronchitis, asthma and bronchiectasis infections and postoperative chest infections; acute and chronic pyelonephritis, cystitis, prostatitis and genitourinary infections; otitis media, otitis externa, sinusitis; maxillary periarthritis, maxillary periostitis , maxillary osteomyelitis; acute uranisconitis, alveolar abscess, periapical periodontitis, opsigenes periodontitis, infection after tooth extraction; hordeolum, blepharitis, acute dacryocystitis; folliculitis, furuncle, erysipelas, cellulitis , impetigo, carbuncle, acne infection, subcutaneous abscess, traumatic infection, mastitis, lymphangitis, etc
【Strength】	0.25g（C₁₆H₁₇N₃O₄S）
【Dosage and Administration】	For adults and children weighing more than 20 kg, the usual dose is 1~2 grams (or 4~8 tablets) daily in two equally divided doses (2~4 tablets each time). Or follow the doctor's advice.